Literature DB >> 35729452

MiRNAs in renal cell carcinoma.

Jesús Miranda-Poma1, Lucía Trilla-Fuertes2, Elena López-Camacho2, Andrea Zapater-Moros2, Rocío López-Vacas2, María Isabel Lumbreras-Herrera2, Ana Pertejo-Fernandez3, Juan Ángel Fresno-Vara2,4,5, Enrique Espinosa-Arranz3, Angelo Gámez-Pozo2,4, Álvaro Pinto-Marín3.   

Abstract

MicroRNAs (miRNAs) are small RNA sequences that act as post-transcriptional regulatory genes to control many cellular processes through pairing bases with a complementary messenger RNA (mRNA). A single miRNA molecule can regulate more than 200 different transcripts and the same mRNA can be regulated by multiple miRNAs. In this review, we highlight the importance of miRNAs and collect the existing evidence on their relationship with kidney cancer.
© 2022. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO).

Entities:  

Keywords:  Kidney cancer; Renal cancer; miRNA; microRNA

Mesh：

Substances：

Year:  2022        PMID： 35729452     DOI： 10.1007/s12094-022-02866-z

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN： 1699-048X            Impact factor:   3.340


  12 in total

1.  SnapShot: MicroRNAs in Cancer.

Authors:  Riccardo Spizzo; Milena S Nicoloso; Carlo M Croce; George A Calin
Journal:  Cell       Date:  2009-05-01       Impact factor: 41.582

2.  A tumor-specific microRNA signature predicts survival in clear cell renal cell carcinoma.

Authors:  Yu-Zheng Ge; Ran Wu; Hui Xin; Meng Zhu; Tian-Ze Lu; Hao Liu; Zheng Xu; Peng Yu; You-Cai Zhao; Ming-Hao Li; Zhi-Kai Hu; Yan Zhao; Bing Zhong; Xiao Xu; Liu-Hua Zhou; Lu-Wei Xu; Jian-Ping Wu; Wen-Cheng Li; Jia-Geng Zhu; Rui-Peng Jia
Journal:  J Cancer Res Clin Oncol       Date:  2015-01-30       Impact factor: 4.553

3.  Down-regulation of miR-497 is associated with poor prognosis in renal cancer.

Authors:  Xiaolei Zhao; Zhenhua Zhao; Wenchao Xu; Junqing Hou; Xinyi Du
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

4.  Microarray analysis of microRNA expression in renal clear cell carcinoma.

Authors:  Y Huang; Y Dai; J Yang; T Chen; Y Yin; M Tang; C Hu; L Zhang
Journal:  Eur J Surg Oncol       Date:  2009-05-13       Impact factor: 4.424

5.  NFκB-mediated cyclin D1 expression by microRNA-21 influences renal cancer cell proliferation.

Authors:  Amit Bera; Nandini Ghosh-Choudhury; Nirmalya Dey; Falguni Das; Balakuntalam S Kasinath; Hanna E Abboud; Goutam Ghosh Choudhury
Journal:  Cell Signal       Date:  2013-08-24       Impact factor: 4.315

6.  MicroRNA-497-5p down-regulation increases PD-L1 expression in clear cell renal cell carcinoma.

Authors:  Fajun Qu; Jianqing Ye; Xiuwu Pan; Junkai Wang; Sishun Gan; Chuanmin Chu; Jian Chu; Xiangmin Zhang; Mei Liu; Hua He; Xingang Cui
Journal:  J Drug Target       Date:  2018-09-11       Impact factor: 5.121

7.  Bortezomib is cytotoxic to the human growth plate and permanently impairs bone growth in young mice.

Authors:  Emma Eriksson; Farasat Zaman; Dionisios Chrysis; Henrik Wehtje; Terhi J Heino; Lars Sävendahl
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

8.  Genistein downregulates onco-miR-1260b and inhibits Wnt-signalling in renal cancer cells.

Authors:  H Hirata; K Ueno; K Nakajima; Z L Tabatabai; Y Hinoda; N Ishii; R Dahiya
Journal:  Br J Cancer       Date:  2013-04-16       Impact factor: 7.640

9.  miR-9-5p in Nephrectomy Specimens is a Potential Predictor of Primary Resistance to First-Line Treatment with Tyrosine Kinase Inhibitors in Patients with Metastatic Renal Cell Carcinoma.

Authors:  Bernhard Ralla; Jonas Busch; Anne Flörcken; Jörg Westermann; Zhongwei Zhao; Ergin Kilic; Sabine Weickmann; Monika Jung; Annika Fendler; Klaus Jung
Journal:  Cancers (Basel)       Date:  2018-09-10       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.